Isotopia and Alpha-9 sign lutetium-177 supply agreement

Isotopia Molecular Imaging and Alpha-9 Theranostics signed a global clinical supply agreement for Isotopia's no-carrier-added lutetium-177 for the preclinical and clinical development of Alpha-9's radiopharmaceutical pipeline.

“Isotopia Molecular Imaging and Alpha-9 Theranostics, are pleased to announce the signing of a global clinical supply agreement that provides Alpha-9 with Isotopia’s medical radioisotope no-carrier-added lutetium-177 for the preclinical and clinical development of Alpha-9’s radiopharmaceutical pipeli”a9oncology.com

• 1 source
• a9oncology.comIsotopia Molecular Imaging and Alpha-9 Theranostics Announce Lutetium-177 Supply Agreement - Alpha-9 OncologyraincastleMay 23, 2022

Summarized from public sources; check the original articles before acting on it.